TEST BANK
LILLEY'S PHARMACOLOGY FOR CANADIAN HEALTH CARE PRACTICE
KARA SEALOCK
4th Edition
TEST BANK
, lOMoAR cPSD| 3013804
lOMoAR cPSD| 3013804
Chapter 01: Nursing Practice in Canada and Drug Therapy
Sealock: Lilley’s Pharmacology for Canadian Health Care Practice, 4th Edition
MULTIPLE CHOICE
1. Which is a judgement about a particular patient’s potential need or problem?
a. A goal
b. An assessment
c. Subjective data
d. A nursing diagnosis
ANS: D
Nursing diagnosis is the phase of the nursing process during which a clinical judgement is made about h
heath conditions and life processes or vulnerability for that response.
DIF: Cognitive Level: Knowledge
2. The patient is to receive oral furosemide (Lasix) every day; however, because the patient is unable to sw
medication orally, as ordered. The nurse needs to contact the physician. What type of problem is this?
a. A “right time” problem
b. A “right dose” problem
c. A “right route” problem
d. A “right medication” problem
ANS: C
This is a “right route” problem: the nurse cannot assume the route and must clarify the route with the p
time” problem because the ordered frequency has not changed. This is not a “right dose” problem beca
an inability to swallow. This is not a “right medication” problem because the medication ordered will n
DIF: Cognitive Level: Application
3. The nurse has been monitoring the patient’s progress on his new drug regimen since the first dose and h
of possible adverse effects. What nursing process phase is the nurse practising?
a. Planning
b. Evaluation
c. Implementation
d. Nursing diagnosis
ANS: B
Monitoring the patient’s progress is part of the evaluation phase. Planning, implementation, and nursing
illustrated by this example.
DIF: Cognitive Level: Application
4. The nurse is caring for a patient who has been newly diagnosed with type 1 diabetes mellitus. Which sta
outcome criterion for this patient?
a. The patient will follow instructions.
b. The patient will not experience complications.
c. The patient adheres to the new insulin treatment regimen.
d. The patient demonstrates safe insulin self-administration technique.
ANS: D
Having the patient demonstrate safe insulin self-administration technique is a specific and measurable o
instructions and avoiding complications are not specific criteria. Adherence to the new insulin treatmen
and would be difficult to measure.
DIF: Cognitive Level: Application
, lOMoAR cPSD| 3013804
6. The nurse is working during a very busy night shift, and the health care provider has just given the nurs
the telephone, but the nurse does not recall the route. What is the best way for the nurse to avoid medic
a. Recopy the order neatly on the order sheet, with the most common route indicated
b. Consult with the pharmacist for clarification about the most common route
c. Call the health care provider to clarify the route of administration
d. Withhold the drug until the health care provider visits the patient
ANS: C
If a medication order does not include the route, the nurse must ask the health care provider to clarify it
administration.
DIF: Cognitive Level: Application | Cognitive Level: Analysis
7. Which constitutes the traditional Five Rights of medication administration?
a. Right drug, right route, right dose, right time, and right patient
b. Right drug, the right effect, the right route, the right time, and the right patient
c. Right patient, right strength, right diagnosis, right drug, and right route
d. Right patient, right diagnosis, right drug, right route, and right time
ANS: A
The traditional Five Rights of medication administration were considered to be Right drug, Right route,
Right patient. Right effect, right strength, and right diagnosis are not part of the traditional Five Rights
DIF: Cognitive Level: Comprehension
8. What correctly describes the nursing process?
a. Diagnosing, planning, assessing, implementing, and finally evaluating
b. Assessing, then diagnosing, implementing, and ending with evaluating
c. A linear direction that begins with assessing and continues through diagnosing,
planning, and finally implementing
d. An ongoing process that begins with assessing and continues with diagnosing,
planning, implementing, and evaluating
ANS: D
The nursing process is an ongoing, flexible, adaptable, and adjustable five-step process that begins with
through diagnosing, planning, implementing, and finally evaluating, which may then lead back to any o
DIF: Cognitive Level: Application
9. When the nurse is considering the timing of a drug dose, which is most important to assess?
a. The patient’s identification
b. The patient’s weight
c. The patient’s last meal
d. Any drug or food allergies
ANS: C
The pharmacokinetic and pharmacodynamic properties of the drug need to be assessed with regard to an
compatibility issues. The patient’s identification, weight, and drug or food allergies are not affected by
DIF: Cognitive Level: Application
10. The nurse is writing nursing diagnoses for a plan of care. Which reflects the correct format for her nurs
a. Anxiety
b. Anxiety related to new drug therapy
c. Anxiety related to anxious feelings about drug therapy, as evidenced by
statements such as “I’m upset about having to give myself shots”
d. Anxiety related to new drug therapy, as evidenced by statements such as “I’m
upset about having to give myself shots”
ANS: D
Formulation of nursing diagnoses is usually a three-step process. The only complete answer is “Anxiet
, lOMoAR cPSD| 3013804
Chapter i02: iPharmacological iPrinciples
Sealock: iLilley’s iPharmacology ifor iCanadian iHealth iCare iPractice, i4th iEdition
MULTIPLE iCHOICE
1. A ipatient iis ireceiving itwo idifferent idrugs, iwhich, iat itheir icurrent idose iforms iand idosages, iare iboth ia
icirculation iin iidentical iamounts. iWhich iterm ibest idenotes ithat ithe idrugs ihave ithe isame iabsorption i
a. Equivalent
b. Synergistic
c. Compatible
d. Bioequivalent
ANS: i D
Two idrugs iabsorbed iinto ithe icirculation iat ithe isame iamount i(in ispecific idosage iforms) ihave ithe
ithey iare ibioequivalent. i“Equivalent” iis iincorrect ibecause ithe iterm i“bioavailability” iis iused ito i
iabsorption.
“Synergistic” iis iincorrect ibecause ithis iterm irefers ito itwo idrugs igiven itogether iwhose iresulting ieff
iof ithe ieffects iof ieach idrug igiven ialone. i“Compatible” iis iincorrect ibecause ithis iterm iis ia igeneral
itwo isubstances ido inot ihave ia ichemical ireaction iwhen imixed i(or igiven, iin ithe icase iof idrugs) itogeth
DIF: Cognitive iLevel: iComprehension
2. A ipatient iis ireceiving imedication ivia iintravenous iinjection. iWhich iinformation ishould ithe inurse iprov
a. The imedication iwill icause ifewer iadverse ieffects iwhen igiven iintravenously.
b. The imedication iwill ibe iabsorbed islowly iinto ithe itissues iover itime.
c. The imedication’s iaction iwill ibegin ifaster iwhen igiven iintravenously.
d. Most iof ithe idrug iis iinactivated iby ithe iliver ibefore iit ireaches ithe itarget iarea.
ANS: i C
Intravenous iinjections iare ithe ifastest iroute iof iabsorption. iThe iintravenous iroute idoes inot iaffect ithe in
ithe iintravenous iroute iis inot ia islow iroute iof iabsorption, iand ithe iintravenous iroute idoes inot icause iin
ithe iliver ibefore iit ireaches ithe itarget iarea.
DIF: Cognitive iLevel: iComprehension
3. Which iis itrue iregarding iparenteral idrugs?
a. They ibypass ithe ifirst-pass ieffect.
b. They idecrease iblood iflow ito ithe istomach.
c. They iare ialtered iby ithe ipresence iof ifood iin ithe istomach.
d. They iexert itheir ieffects iwhile icirculating iin ithe ibloodstream.
ANS: i A
Drugs igiven iby ithe iparenteral iroute ibypass ithe ifirst-pass ieffect, ibut ithey istill imust ibe iabsorbed iinto ic
ican iexert itheir ieffects. iEnteral idrugs i(drugs itaken iorally), inot iparenteral idrugs, idecrease iblood iflow
i altered iby ithe ipresence iof ifood iin ithe istomach. iParenteral idrugs imust ibe iabsorbed iinto icells iand iti
ibefore ithey ican iexert itheir ieffects; ithey ido inot iexert itheir ieffects iwhile icirculating iin ithe ibloodstrea
DIF: Cognitive iLevel: iAnalysis
4. A idrug’s ihalf-life iis ibest idefined ias
a. The itime iit itakes ifor ithe idrug ito ielicit ihalf iits itherapeutic iresponse.
b. The itime iit itakes ione-half iof ithe ioriginal iamount iof ia idrug ito ireach ithe
itarget icells.
c. The itime iit itakes ione-half iof ithe ioriginal iamount iof ia idrug ito ibe iremoved ifrom
ithe ibody.
d. The itime iit itakes ione-half iof ithe ioriginal iamount iof ia idrug ito ibe iabsorbed iinto
ithe icirculation.
ANS: i C
LILLEY'S PHARMACOLOGY FOR CANADIAN HEALTH CARE PRACTICE
KARA SEALOCK
4th Edition
TEST BANK
, lOMoAR cPSD| 3013804
lOMoAR cPSD| 3013804
Chapter 01: Nursing Practice in Canada and Drug Therapy
Sealock: Lilley’s Pharmacology for Canadian Health Care Practice, 4th Edition
MULTIPLE CHOICE
1. Which is a judgement about a particular patient’s potential need or problem?
a. A goal
b. An assessment
c. Subjective data
d. A nursing diagnosis
ANS: D
Nursing diagnosis is the phase of the nursing process during which a clinical judgement is made about h
heath conditions and life processes or vulnerability for that response.
DIF: Cognitive Level: Knowledge
2. The patient is to receive oral furosemide (Lasix) every day; however, because the patient is unable to sw
medication orally, as ordered. The nurse needs to contact the physician. What type of problem is this?
a. A “right time” problem
b. A “right dose” problem
c. A “right route” problem
d. A “right medication” problem
ANS: C
This is a “right route” problem: the nurse cannot assume the route and must clarify the route with the p
time” problem because the ordered frequency has not changed. This is not a “right dose” problem beca
an inability to swallow. This is not a “right medication” problem because the medication ordered will n
DIF: Cognitive Level: Application
3. The nurse has been monitoring the patient’s progress on his new drug regimen since the first dose and h
of possible adverse effects. What nursing process phase is the nurse practising?
a. Planning
b. Evaluation
c. Implementation
d. Nursing diagnosis
ANS: B
Monitoring the patient’s progress is part of the evaluation phase. Planning, implementation, and nursing
illustrated by this example.
DIF: Cognitive Level: Application
4. The nurse is caring for a patient who has been newly diagnosed with type 1 diabetes mellitus. Which sta
outcome criterion for this patient?
a. The patient will follow instructions.
b. The patient will not experience complications.
c. The patient adheres to the new insulin treatment regimen.
d. The patient demonstrates safe insulin self-administration technique.
ANS: D
Having the patient demonstrate safe insulin self-administration technique is a specific and measurable o
instructions and avoiding complications are not specific criteria. Adherence to the new insulin treatmen
and would be difficult to measure.
DIF: Cognitive Level: Application
, lOMoAR cPSD| 3013804
6. The nurse is working during a very busy night shift, and the health care provider has just given the nurs
the telephone, but the nurse does not recall the route. What is the best way for the nurse to avoid medic
a. Recopy the order neatly on the order sheet, with the most common route indicated
b. Consult with the pharmacist for clarification about the most common route
c. Call the health care provider to clarify the route of administration
d. Withhold the drug until the health care provider visits the patient
ANS: C
If a medication order does not include the route, the nurse must ask the health care provider to clarify it
administration.
DIF: Cognitive Level: Application | Cognitive Level: Analysis
7. Which constitutes the traditional Five Rights of medication administration?
a. Right drug, right route, right dose, right time, and right patient
b. Right drug, the right effect, the right route, the right time, and the right patient
c. Right patient, right strength, right diagnosis, right drug, and right route
d. Right patient, right diagnosis, right drug, right route, and right time
ANS: A
The traditional Five Rights of medication administration were considered to be Right drug, Right route,
Right patient. Right effect, right strength, and right diagnosis are not part of the traditional Five Rights
DIF: Cognitive Level: Comprehension
8. What correctly describes the nursing process?
a. Diagnosing, planning, assessing, implementing, and finally evaluating
b. Assessing, then diagnosing, implementing, and ending with evaluating
c. A linear direction that begins with assessing and continues through diagnosing,
planning, and finally implementing
d. An ongoing process that begins with assessing and continues with diagnosing,
planning, implementing, and evaluating
ANS: D
The nursing process is an ongoing, flexible, adaptable, and adjustable five-step process that begins with
through diagnosing, planning, implementing, and finally evaluating, which may then lead back to any o
DIF: Cognitive Level: Application
9. When the nurse is considering the timing of a drug dose, which is most important to assess?
a. The patient’s identification
b. The patient’s weight
c. The patient’s last meal
d. Any drug or food allergies
ANS: C
The pharmacokinetic and pharmacodynamic properties of the drug need to be assessed with regard to an
compatibility issues. The patient’s identification, weight, and drug or food allergies are not affected by
DIF: Cognitive Level: Application
10. The nurse is writing nursing diagnoses for a plan of care. Which reflects the correct format for her nurs
a. Anxiety
b. Anxiety related to new drug therapy
c. Anxiety related to anxious feelings about drug therapy, as evidenced by
statements such as “I’m upset about having to give myself shots”
d. Anxiety related to new drug therapy, as evidenced by statements such as “I’m
upset about having to give myself shots”
ANS: D
Formulation of nursing diagnoses is usually a three-step process. The only complete answer is “Anxiet
, lOMoAR cPSD| 3013804
Chapter i02: iPharmacological iPrinciples
Sealock: iLilley’s iPharmacology ifor iCanadian iHealth iCare iPractice, i4th iEdition
MULTIPLE iCHOICE
1. A ipatient iis ireceiving itwo idifferent idrugs, iwhich, iat itheir icurrent idose iforms iand idosages, iare iboth ia
icirculation iin iidentical iamounts. iWhich iterm ibest idenotes ithat ithe idrugs ihave ithe isame iabsorption i
a. Equivalent
b. Synergistic
c. Compatible
d. Bioequivalent
ANS: i D
Two idrugs iabsorbed iinto ithe icirculation iat ithe isame iamount i(in ispecific idosage iforms) ihave ithe
ithey iare ibioequivalent. i“Equivalent” iis iincorrect ibecause ithe iterm i“bioavailability” iis iused ito i
iabsorption.
“Synergistic” iis iincorrect ibecause ithis iterm irefers ito itwo idrugs igiven itogether iwhose iresulting ieff
iof ithe ieffects iof ieach idrug igiven ialone. i“Compatible” iis iincorrect ibecause ithis iterm iis ia igeneral
itwo isubstances ido inot ihave ia ichemical ireaction iwhen imixed i(or igiven, iin ithe icase iof idrugs) itogeth
DIF: Cognitive iLevel: iComprehension
2. A ipatient iis ireceiving imedication ivia iintravenous iinjection. iWhich iinformation ishould ithe inurse iprov
a. The imedication iwill icause ifewer iadverse ieffects iwhen igiven iintravenously.
b. The imedication iwill ibe iabsorbed islowly iinto ithe itissues iover itime.
c. The imedication’s iaction iwill ibegin ifaster iwhen igiven iintravenously.
d. Most iof ithe idrug iis iinactivated iby ithe iliver ibefore iit ireaches ithe itarget iarea.
ANS: i C
Intravenous iinjections iare ithe ifastest iroute iof iabsorption. iThe iintravenous iroute idoes inot iaffect ithe in
ithe iintravenous iroute iis inot ia islow iroute iof iabsorption, iand ithe iintravenous iroute idoes inot icause iin
ithe iliver ibefore iit ireaches ithe itarget iarea.
DIF: Cognitive iLevel: iComprehension
3. Which iis itrue iregarding iparenteral idrugs?
a. They ibypass ithe ifirst-pass ieffect.
b. They idecrease iblood iflow ito ithe istomach.
c. They iare ialtered iby ithe ipresence iof ifood iin ithe istomach.
d. They iexert itheir ieffects iwhile icirculating iin ithe ibloodstream.
ANS: i A
Drugs igiven iby ithe iparenteral iroute ibypass ithe ifirst-pass ieffect, ibut ithey istill imust ibe iabsorbed iinto ic
ican iexert itheir ieffects. iEnteral idrugs i(drugs itaken iorally), inot iparenteral idrugs, idecrease iblood iflow
i altered iby ithe ipresence iof ifood iin ithe istomach. iParenteral idrugs imust ibe iabsorbed iinto icells iand iti
ibefore ithey ican iexert itheir ieffects; ithey ido inot iexert itheir ieffects iwhile icirculating iin ithe ibloodstrea
DIF: Cognitive iLevel: iAnalysis
4. A idrug’s ihalf-life iis ibest idefined ias
a. The itime iit itakes ifor ithe idrug ito ielicit ihalf iits itherapeutic iresponse.
b. The itime iit itakes ione-half iof ithe ioriginal iamount iof ia idrug ito ireach ithe
itarget icells.
c. The itime iit itakes ione-half iof ithe ioriginal iamount iof ia idrug ito ibe iremoved ifrom
ithe ibody.
d. The itime iit itakes ione-half iof ithe ioriginal iamount iof ia idrug ito ibe iabsorbed iinto
ithe icirculation.
ANS: i C
